Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 1/20 | 0.41 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.34 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.34 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.34 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.34 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27037217 | 0.78 | NAPRT (0.41) | PIK3CDNAPRTPOLBDGAT1SMN1; SMN2 | |
| SCHEMBL10522128 | 0.69 | LMNA (0.44) | CYP2A6NPC1RAB9AMAPTALDH1A1 | |
| SCHEMBL1145624 | 0.64 | — | — | |
| SCHEMBL82409 | 0.64 | — | — | |
| SCHEMBL1090665 | 0.64 | SMN1; SMN2 (0.44) | PIK3CDNAPRTSMN1; SMN2NPC1RAB9A | |
| SCHEMBL1662273 | 0.63 | PIK3CD (0.73) | PIK3CDNAPRTPOLBADRA2AADRA2B | |
| SCHEMBL29538085 | 0.63 | — | — | |
| SCHEMBL17800 | 0.63 | — | — | |
| SCHEMBL19726386 | 0.62 | CYP2A6 (0.42) | NAPRTCYP2A6SMN1; SMN2MAPTALDH1A1 | |
| SCHEMBL18343594 | 0.62 | PIK3CD (0.41) | PIK3CDNAPRTPOLBADRA2AADRA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119855818-A | Compound and application thereof in treatment of chronic hepatitis B, hepatic fibrosis and liver cancer | 河北乌图药业有限公司 | 2025-04-18 | — | — | CN | disclosed |
| WO-2024217429-A1 | COMPOUND AND USE THEREOF IN TREATMENT OF CHRONIC HEPATITIS B, HEPATIC FIBROSIS AND LIVER CANCER | 河北乌图药业有限公司 | 2024-10-24 | — | — | WO | disclosed |
| WO-2024217452-A1 | COMPOUND AND USE THEREOF IN TREATMENT OF CHRONIC HEPATITIS B, LIVER FIBROSIS, AND LIVER CANCER | 河北乌图药业有限公司 | 2024-10-24 | — | — | WO | disclosed |